| Aditya Ultra Steel Ltd [27-Jun-26] |
Pursuant to Regulation 30 of the Listing Regulations, we wish to inform you that after considering there commendation and report of the Audit Committee and the Committee of Independent Directors, the Board of Directors of Aditya Ultra Steel Limited AUSL Transferor Company Amalgamating Company the Company, at its meeting held today, on 27th June, 2026, has considered and approved a Scheme of Amalgamation Scheme for the merger of the Company into VMS TMT Limited VMS Transferee Company Amalgamated Company and their respective shareholders and creditors, under Section 230 to232 of the Companies Act, 2013(Act) and other applicable laws including the rules and regulations (Proposed Transaction) |
| VMS TMT Ltd [27-Jun-26] |
Pursuant to Regulation 30 of the Listing Regulations, we wish to inform you that after considering there commendation and report of the Audit Committee and the Committee of Independent Directors, the Board of Directors of Aditya Ultra Steel Limited AUSL Transferor Company Amalgamating Company the Company, at its meeting held today, on 27th June, 2026, has considered and approved a Scheme of Amalgamation Scheme for the merger of the Company into VMS TMT Limited VMS Transferee Company Amalgamated Company and their respective shareholders and creditors, under Section 230 to232 of the Companies Act, 2013(Act) and other applicable laws including the rules and regulations (Proposed Transaction)
|
| Ipca Laboratories Ltd [26-Jun-26] |
This is to inform you that at the meeting of the Board of Directors of the Company held today, the Board has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. (Transferor Company) with the Company (Ipca Laboratories Ltd.) (Transferee Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. |
| Krebs Biochemicals & Industries Ltd [26-Jun-26] |
This is to inform you that at the meeting of the Board of Directors of the Company held today, the Board has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. (Transferor Company) with the Company (Ipca Laboratories Ltd.) (Transferee Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. |
| Kisan Mouldings Ltd [26-Jun-26] |
SCRIP Code: 531761
NSE Symbol: APOLLOPIPE
Outcome of Board Meeting |